VIKING THERAPEUTICS INC (VKTX)
US92686J1060 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -93.72M | -85.89M | -68.87M | -54.99M | -39.50M | |||
| Change In Working Capital | 27.90M | 3.55M | 10.19M | -2.93M | 7.72M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 10.95M | 8.97M | 10.28M | 10.33M | 10.00M | |||
| OPERATING CASH FLOW | -54.87M | -73.38M | -48.40M | -47.59M | -21.78M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | -641.08M | -179.09M | 54.75M | 37.96M | 41.57M | |||
| INVESTING CASH FLOW | -641.08M | -179.09M | 54.75M | 37.96M | 41.57M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 7.16M | 6.77M | -5.95M | 7.63M | 1.27M | |||
| Other Financing Activity | 866.06M | 264.61M | 10.11M | -750.00K | -320.00K | |||
| FINANCING CASH FLOW | 873.23M | 271.38M | 4.16M | 6.88M | 950.00K | |||
| Exchange Rate Effect | -68.00K | -30.00K | -260.00K | N/A | N/A | |||
| CHANGE IN CASH | 177.22M | 18.88M | 10.25M | -2.75M | 20.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -54.87M | -73.38M | -48.40M | -47.59M | -21.78M | |||
| FREE CASH FLOW | -54.87M | -73.38M | -48.40M | -47.59M | -21.78M | |||
All data in USD